From: Becker's GI & Endoscopy <editorial@beckershealthcare.com>
Subject: CMS will cancel major bundled payment initiatives | How effective is fecal immunochemical testing for colorectal cancer? | Top US surgeons, ASC administrators & more attending Becker's Oct. conf. Reg. today! | 5 most-read GI/endoscopy stories
Preheader:
Reply: editorial@beckershealthcare.com
View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ 

               
 
August 15, 2017 
Today's Top Stories
1. How effective is fecal immunochemical testing for colorectal cancer? 

2. CMS will cancel major bundled payment initiatives Full story

3. The Joint Commission's new toolkit aims to make ambulatory surgery safer - 3 insights Full story

4. Some of the nation's top surgeons, administrators and ASC business and clinical leaders are attending Becker's ASC 24th Annual Meeting: The Business and Operations of ASCs. Don't miss out on this opportunity to learn key trends sweeping the healthcare industry. To learn more and register, click here. 

5. Swedish Health's Cherry Hill campus at risk of losing Medicare, Medicaid funding Full story

6. 5 most-read GI/endoscopy stories: Aug.7-11 Full story

7. GI leader to know: Dr. Neil Price of GastroIntestinal Health  Full story
   
8. How much practices spend per physician on federal regulations: 5 key statistics  Full story

9. ASCs could save $10.5B with 80% penetration in 50 largest US cities: 5 key trends Full story

10. GI center to know: GastroIntestinal Health 
Full story 
 
11. 7 things for healthcare leaders to know  Full story 
               
                                                        
              
               
              
Channels
_____________________
Contact Us

Editorial Contact: 
Laura Dyrda   
Editor in Chief  
(312) 253-9170
email Laura

Sales, Marketing & Events:
Jessica Cole
President and CEO
______________________
 
   
Becker's ASC Review
A Becker's Healthcare Publication
17 N. State, Suite 1800| Chicago, IL 60602